Rheumatic and autoimmune thyroid disorders: A causal or casual relationship?

Autoimmunity Reviews

Volumn 14, Issue 1, 2015, Pages 57-63

  Bourji, Khalil ^a   Gatto, Mariele ^a   Cozzi, Franco ^a   Doria, Andrea ^a   Punzi, Leonardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT;

ARTHRALGIA; ARTHRITIS; AUTOIMMUNE DISEASE; DRUG INDUCED DISEASE; FIBROMYALGIA; GENETIC ASSOCIATION; HUMAN; HUMEROSCAPULAR PERIARTHRITIS; MUSCLE WEAKNESS; MYALGIA; NEUROLOGIC DISEASE; POLYARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THYROID DISEASE; VASCULITIS; ANIMAL; COMPLICATION; GENETIC VARIABILITY; IMMUNOLOGY; PATHOLOGY; PREVALENCE; PROBABILITY; THYROID GLAND;

ANIMALS; AUTOIMMUNE DISEASES; GENETIC VARIATION; HUMANS; PREVALENCE; PROBABILITY; RHEUMATIC DISEASES; THYROID DISEASES; THYROID GLAND;

EID: 84922932145     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.10.007     Document Type: Review

References (113)

1. Lazurova I., Benhatchi K. Autoimmune thyroid diseases and nonorgan-specific autoimmunity. Pol Arch Med Wewn 2012, 122:55-59.
2. Weetman A.P. The immunopathogenesis of chronic autoimmune thyroiditis one century after Hashimoto. Eur Thyroid J 2012, 1:243-250.
3. Punzi L., Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 2004, 71:275-283.
4. Kaplan G., Vinceneux P., Bourgeois P., Kahn M.F. Syndrome de Gougerot-Sjögren, connectivites et pathologie autoimmune. Rev Rheumatol 1977, 44:471-478.
5. Hansen B.U., Ericsson U.B., Henricsson V., et al. Autoimmune thyroiditis and primary Sjögren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol 1991, 9:137-141.
6. Crowe J.P., Christensen E., Butler J., et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 1980, 78:1437-1441.
7. Kelly C.A., Foster H., Pal B., et al. Primary Sjögren's syndrome in north east England-a longitudinal study. Br J Rheumatol 1991, 30:437-442.
8. Pérez B., Kraus A., López G., Cifuentes M., Alarcón-Segovia D. Autoimmune thyroid disease in primary Sjögren's syndrome. Am J Med 1995, 99:480-484.
9. Vitali C., Bombardieri S., Moutsopoulos H.M., et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36(3):340-347.
10. Punzi L., Ostuni P.A., Betterle C., et al. Thyroid gland disorders in primary Sjögren's syndrome. Rev Rhum Engl 1996, 63:809-814.
11. Ramos-Casals M., García-Carrasco M., Cervera R., et al. Thyroid disease in primary Sjögren's syndrome. Study in a series of 160 patients. Medicine (Baltimore) 2000, 79:103-108.
12. Scofield R.H., Bruner G.R., Harley J.B., Namjou B. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren's syndrome in familial systemic lupus. Ann Rheum Dis 2007, 66:410-413.
13. Caramaschi P., Biasi D., Caimmi C., et al. The co-occurrence of Hashimoto thyroiditis in primary Sjögren's syndrome defines a subset of patients with milder clinical phenotype. Rheumatol Int 2013, 33:1271-1275.
14. White R.G., Bass B.H., Williams E. Lymphadenoid goitre and the syndrome of systemic lupus erythematosus. Lancet 1961, 1(7173):368-373.
15. Hijmans W., Doniach D., Roitt I.M., Holborow E.J. Serological overlap between lupus erythematosus, rheumatoid arthritis, and thyroid autoimmune disease. Br Med J 1961, 2(5257):909-914.
16. Scofield R.H. Autoimmune thyroid disease in systemic lupus erythematosus and Sjögren's syndrome. Clin Exp Rheumatol 1996, 14(3):321-330.
17. Chan A.T., Al-Saffar Z., Bucknall R.C. Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology 2001, 40:353-354.
18. Pyne D., Isenberg D.A. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 2002, 61:70-72.
19. Mulhern L.M., Masi A.T., Shulman L.E. Hashimoto's disease: a search for associated disorders in 170 clinically detected cases. Lancet 1966, 3:508-511.
20. Silman A.J., Ollier W.E., Bubel M.A. Autoimmune thyroid disease and thyroid autoantibodies in rheumatoid arthritis patients and their families. Br J Rheumatol 1989, 28:18-21.
21. Shiroky J.B., Cohen M., Ballachey M.L., Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 1993, 52:454-456.
22. Przygodzka M., FilipowiczSosnowska A. Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis. Pol Arch Med Wewn 2009, 119:39-43.
23. McCoy S.S., Crowson C.S., Gabriel S.E., Matteson E.L. Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol 2012, 39(5):954-958.
24. Cárdenas Roldán J., Amaya-Amaya J., Castellanos-de la Hoz J., et al. Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis 2012, 2012. (Article ID 864907).
25. Becker K.L., Ferguson R.H., McConahey W.M. The connective tissue diseases and symptoms associated with Hashimoto's thyroiditis. N Engl J Med 1963, 268:277-280.
26. Kahl L.E., Medsger T.A., Klein I. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol 1986, 13:103-107.
27. Gordon M.B., Klein I., Dekker A., Rodnan G.P., Medsger T.A. Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med 1981, 95:431-435.
28. Molteni M., Barili M., Eisera N., et al. Anti-thyroid antibodies in Italian scleroderma patients: association of anti-thyroid peroxidase (anti-TPO) antibodies with HLA-DR15. Clin Exp Rheumatol 1997, 15:529-534.
29. Antonelli A., Ferri C., Fallahi P., et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007, 156:431-437.
30. Vera-Lastra O.L., Medina-García G., Guadalupe-Reséndiz-Pérez L., et al. Systemic sclerosis and hypothyroidism. Gac Med Mex 2007, 143(6):471-475.
31. Marasini B., Ferrari P.A., Solaro N., Selmi C. Thyroid dysfunction in women with systemic sclerosis. Ann N Y Acad Sci 2007, 108:305-311.
32. Danielides S., Mavragani C.P., Katsakoulas I., et al. Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. Scand J Rheumatol 2011, 40(4):299-303.
33. Dent R.G., Edwards O.M. Autoimmune thyroid disease and the polymyalgia rheumatica-giant cell arteritis syndrome. Clin Endocrinol (Oxf) 1978, 9:215-219.
34. Juchet H., Labarthe M.P., Ollier S., Vilain C., Arlet P. Prevalence of hypothyroidism and hyperthyroidism in temporal arteritis and rhizomelic pseudopolyarthritis. A controlled study of 104 cases. Rev Rhum 1993, 60:493-498.
35. Myklebust G., Gran J.T. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996, 35:1161-1168.
36. Korinek J., Lubanda J.C., Karetova D., et al. Takayasu's disease associated with autoimmune thyroiditis and celiac disease. Clinical course and limitations of treatment. J Mal Vasc 2001, 26:191-195.
37. Magro C.M., Crowson A.N. A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol 1999, 21:234-240.
38. Akdeniz S., Colak S., Tuzcu A.K., Bahceci M., Harman M. Baseline and stimulated thyroid functions in Behçet's disease. JEADV 2006, 20:868-902.
39. Cebeci F., Onsun N., Pekdemir A., Uras A.R., Kayataş K. Thyroid autoimmunity and Behçet's disease: is there a significant association?. Scientific World Journal 2013, 2013. (Article ID 956837). 10.1155/2013/956837.
40. Haapala A.M., Hyöty H., Parkkonen P., Mustonen J., Soppi E. Antibody reactivity against thyroid peroxidase and myeloperoxidase in autoimmune thyroiditis and systemic vasculitis. Scand J Immunol 1997, 46:78-85.
41. Leriche N.G.H., Bell D.A. Hashimoto's thyroiditis and polyarthritis: a possible subset of seronegative polyarthritis. Ann Rheum Dis 1984, 43:594-598.
42. Punzi L., Michelotto M., Pianon M., et al. Clinical, laboratory and immunogenetic aspects of arthritis associated with chronic lymphocytic thyroiditis. Clin Exp Rheumatol 1997, 15:373-380.
43. Golding D.N. Rheumatism and the thyroid. J R Soc Med 1993, 86:130-132.
44. Blake D.R., McGregor A.M., Stansfield E., Smith B.R. Antithyroid antibody activity in the synovial fluid of patients with various arthritides. Lancet 1979, 2:224-226.
45. Punzi L., Schiavon F., Ramonda R., et al. Anti-thyroid antibody in synovial fluid as a revealing feature of seronegative autoimmune thyroiditis. Clin Rheumatol 1991, 10:181-183.
46. Dorwart B.B., Schumacher H.R. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism. A clinicopathologic study. Am J Med 1975, 59(6):780-790.
47. Job-Deslandre C., Menkes C.J., Guinot M., Luton J.P. Does hypothyroidism increase the prevalence of chondrocalcinosis?. Br J Rheumatol 1993, 32:197-198.
48. Giordano N., Santacroce C., Mattii G., et al. Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol 2001, 19(6):661-665.
49. Hunter T., Chalmers I.M., Dube W.J., Schroeder M.L. Episodic polyarthralgia associated with Hashimoto's thyroiditis. Arthritis Rheum 1988, 31:303.
50. Punzi L., Sfriso P., Pianon M., et al. Clinical manifestations and outcome of polyarthralgia associated with chronic lymphocytic thyroiditis. Semin Arthritis Rheum 2002, 32:51-55.
51. Takasu N., Komiya I., Asawa T., Nagasawa Y., Yamada T. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto's thyroiditis. Lancet 1990, 336:1084-1086.
52. Tagoe C.E., Zezon A., Khattri S., Castellanos P. Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. Rheumatol Int 2013, 33:1745-1752.
53. Goette D.K. Thyroid acropachy. Arch Dermatol 1980, 166:205-206.
54. Seigel R.S., Thrall J.H., Sisson J.C. Tc-pyrophosphate scan and radiographic correlation in thyroid acropachy: case report. J Nucl Med 1976, 17:791-793.
55. Fatourechi V., Ahmed D.D., Schwartz K.M. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab 2002, 87:5435-5441.
56. Scanlon G.T., Clemett A.R. Thyroid acropachy. Radiology 1964, 83:1039-1042.
57. Gorman C.A. Unusual manifestations of Graves' disease. Mayo Clin Proc 1972, 47:926-933.
58. Taroumian S., Naylor S.M., Ben-Artzi A. Clinical Images: Ultrasonographic appearance of thyroid acropachy. Arthritis Rheum 2012, 64(9):3033.
59. Siegel L.B., Cohen N.J., Gall E.P. Adhesive capsulitis: a sticky issue. Am Fam Physician 1999, 59:1843-1850.
60. Baran D.T. The skeletal system in thyrotoxicosis. Werner and Ingbar's the thyroid 2000.
61. Cakir M., Samanci N., Balci N., Balci M.K. Musculoskeletal manifestations in patients with thyroid disease. Clin Endocrinol (Oxf) 2003, 59:162-167.
62. Williams G.R. Thyroid hormone actions in cartilage and bone. Eur Thyroid J 2013, 2(1):3-13.
63. Robson H., Siebler T., Stevens D.A., Shalet S.M., Williams G.R. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 2000, 141:3887-3897.
64. Meunier P.J., S-Bianchi G.G., Edouard C.M. Bony manifestations of thyrotoxicosis. Orthop Clin North Am 1972, 3:745-774.
65. Cummings S.R., Nevitt M.C., Browner W.S. Risk factors for hip fractures in white women. N Engl J Med 1995, 332:767-773.
66. Langdahl B.L., Loft A.G., Eriksen E.F. Bone mass, bone turnover, bone composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 1996, 6:161-168.
67. Karga H., Papapetrou P.D., Korakovouni A. Bone mineral density in hyperthyroidism. Clin Endocrinol (Oxf) 2004, 61:466-472.
68. Al-Shoumer K.A., Vasanthy B.A., Al-Zaid M.M. Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr Pract 2006, 12:121-130.
69. Vestergaard P., Rejnmark L., Mosekilde L. Influence of hyper- and hypothyroidism and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 2005, 77:139-144.
70. Khaleeli A.A., Griffith D.G., Edwards R.H. The clinical presentation of hypothyroid myopathy. Clin Endocrinol 1983, 19:365-376.
71. Lebrun C., Jullien D., Thomas P., Sadoul J.L. Manifestations neuromusculaires des disthyroïdies. Ann Med Interne 1993, 144:472-481.
72. Monzani F., Caraccio N., Siciliano G., et al. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab 1997, 82:3315-3318.
73. Pamuk O.N., Cakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 2007, 26:55-59.
74. Suk J.H., Lee J.H., Kim J.M. Association between thyroid autoimmunity and fibromyalgia. Exp Clin Endocrinol Diabetes 2012, 120:401-404.
75. Deepak S., Harikrishnan, Jayakumar B. Hypothyroidism presenting as Hoffman's syndrome. J Indian Med Assoc 2004, 102(1):41-42.
76. Vasconcellos L.F., Peixoto M.C., de Oliveira T.N., Penque G., Leite A.C. Hoffman's syndrome: pseudohypertrophic myopathy as initial manifestation of hypothyroidism. Case report. Arq Neuropsiquiatr 2003, 61:3B.
77. Mastropasqua M., Spagna G., Baldini V., Tedesco I., Paggi A. Hoffman's syndrome: muscle stiffness, pseudohypertrophy and hypothyroidism. Horm Res 2003, 59(2):105-108.
78. Turker H., Bayrak O., Gungor L., et al. Hypothyroid myopathy with manifestations of Hoffman's syndrome and myasthenia gravis. Thyroid 2008, 18:2.
79. Tullu M.S., Udgirkar V.S., Muranjan M.N., Sathe S.A., Kamat J.R. Kocher-Debre-Semelaigne syndrome: hypothyroidism with muscle hypertrophy. Indian J Pediatr 2003, 70:671-673.
80. Ibrahim I., Khan W.S., Goddard N., Smitham P. Carpal tunnel syndrome: a review of the recent literature. Open Orthop J 2012, 6:69-76.
81. Palumbo C.F., Szabo R.M., Olmsted S.L. The effects of hypothyroidism and thyroid replacement on the development of carpal tunnel syndrome. J Hand Surg 2000, 25A:4.
82. Duyff R.F.Van, den Bosch J., van Laman D.M., Loon B.J., Linssen W.H. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 2000, 68:750-755.
83. Eslamian F., Bahrami A., Aghamohammadzadeh N., et al. Electrophysiologic changes in patients with untreated primary hypothyroidism. J Clin Neurophysiol 2011, 28(3):323-328.
84. Suresh E., Morris I.M. How valuable is screening for thyroid disease in patients with carpal tunnel syndrome?. J Clin Rheumatol 2004, 10(3):116-118.
85. Menconi F., Marcocci C., Marinò M. Diagnosis and classification of Graves' disease. Autoimmun Rev 2014, 13:398-402.
86. Cooper D.S. Antithyroid drugs. N Engl J Med 2005, 352:905-917.
87. Shabtai R., Shapiro M.S., Orenstein D., Taragan R., Shenkman L. The antithyroid arthritis syndrome reviewed. Arthritis Rheum 1984, 27:227-229.
88. Dolman K.M., Gans R.O., Vervaat T.J., et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993, 342:651-652.
89. Harper L., Chin L., Daykin J., et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol 2004, 60:671-675.
90. Vanek C., Samuels M.H. Central nervous system vasculitis caused by propylthiouracil therapy: a case report and literature review. Thyroid 2005, 15(1):80-84.
91. Kimura M., Seki T., Ozawa H., et al. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant. Endocr J 2013, 60(3):383-388.
92. Bonaci-Nikolic B., Nikolic M.M., Andrejevic S., Zoric S., Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005, 7:1072-1081.
93. Ashizawa, Eguchi Serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease receiving antithyroid medication. Intern Med 2003, 42:6.
94. Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651-1657.
95. Helfgott S.M., Smith R.N. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2002. A 21-year-old man with arthritis during treatment for hyperthyroidism. N Engl J Med 2002, 347:122-130.
96. Waldhauser L., Uetrecht J. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils: implications for agranulocytosis. Drug Metab Dispos 1991, 19:354-359.
97. Sève P., Stankovic K., Michalet V., et al. Carbimazole induced eosinophilic granulomatous vasculitis localized to the stomach. J Intern Med 2005, 258:191-195.
98. Ozkok A., Kaya S., Elcioglu O.C., Odabas A.R. Propylthiouracil-induced cryoglobulinemic vasculitis. Intern Med 2013, 52:2011-2012.
99. Bou Khalil R., Abou Salbi M., Sissi S., et al. Methimazole-induced myositis: a case report and review of the literature. Endocrinology diabetes and metabolism case reports 13-0008 2013.
100. Lim A.Y., Kek P.C., Soh A.W. Carbimazole-induced myositis in the treatment of Graves' disease: a complication in genetically susceptible individuals?. Singapore Med J 2013, 54(7):e133-e136.
101. Seo J.Y., Byun H.J., Cho K.H., Lee E.B. Methimazole-induced bullous systemic lupus erythematosus: a case report. J Korean Med Sci 2012, 27:818-821.
102. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
103. Tomer Y., Ban Y., Concepcion E., et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003, 73:736-747.
104. Tomer Y., Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003, 24:694-717.
105. Jacobson E.M., Huber A., Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008, 30(1-2):58-62.
106. Robazzi T., Adan L. Autoimmune thyroid disease in patients with rheumatic diseases. Rev Bras Reumatol 2012, 52(3):417-430.
107. Gatto M., Zen M., Ghirardello A., et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 2013, 12(4):523-536.
108. Tomer Y., Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009, 32:231-239.
109. Effraimidis G., Wiersinga W.M. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol 2014, 170:R241-R252.
110. George G. Hypothyroidism presenting as puzzling myalgias and cramps in 3 patients. J Clin Rheumatol 2007, 13:273-275.
111. Yi J., Zheng J.Y., Zhang W., et al. Decreased pain threshold and enhanced synaptic transmission in the anterior cingulate cortex of experimental hypothyroidism mice. Mol Pain 2014, 10:38.
112. Ranka R., Mathur R. Serum creatine phosphokinase in thyroid disorders. Indian J Clin Biochem 2003, 18:107-110.
113. Summachiwakij S., Sachmechi I. Rhabdomyolysis induced by nonstrenuous exercise in a patient with Graves' disease. Case Rep Endocrinol 2014, 286450. [Epub ahead of print].